Efficacy and side effects of intermittent intravenous and oral doxercalciferol (1α-hydroxyvitamin D2) in dialysis patients with secondary hyperparathyroidism: A sequential comparison

✍ Scribed by Maung, Hla M.; Elangovan, Loganathan; Frazão, João M.; Bower, John D.; Kelley, Bobby J.; Acchiardo, Sergio R.; Rodriguez, Hector J.; Norris, Keith C.; Sigala, Jerald F.; Rutkowski, Mark; Robertson, John A.; Goodman, William G.; Levine, Barton S.; Chesney, Russell W.; Mazess, Richard B.; Kyllo, Darlene M.; Douglas, Laura L.; Bishop, Charles W.; Coburn, Jack W.

• Book ID: 122044534
• Publisher: Elsevier Science
• Year: 2001
• Tongue: English
• Weight: 349 KB
• Volume: 37
• Category: Article
• ISSN: 0272-6386
• DOI: 10.1016/S0272-6386(01)80010-X